Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) is anticipated to release its earnings data before the market opens on ...

Atossa Therapeutics, Inc. (($ATOS)) has held its Q4 earnings call. Read on for the main highlights of the call. Atossa Therapeutics’ recent ...

Just because a business does not make any money, does not mean that the stock will go down. For example, although Amazon.com made losses for many years after listing, if you had bought and held the ...

Good morning, everyone, and welcome to the Atossa Therapeutics fourth quarter and full year 2024 earnings conference call. My name is Joelle, and I will be your conference operator today. (Operator ...

Atossa Therapeutics Inc (ATOS) reports reduced operating expenses and promising developments in its lead program, Z-endoxifen, while maintaining a strong cash position.

Metastatic breast cancer remains an area of critical unmet need, where improved therapies are urgently required,” said Steven Quay, M.D., ...

Today, several major companies are expected to report earnings: Canadian Solar (CSIQ), Cormedix (CRMD), GameStop (GME), ...

Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) will likely be posting its quarterly earnings results on Tuesday, March ...

Option chain shows key data for Atossa Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market ...

SEATTLE, March 20, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company ...

SEATTLE, March 20, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast ...